Kiromic Biopharma, Inc. Convertible Debt, Current
Kiromic Biopharma, Inc. had Convertible Debt, Current of $13.24 million as of 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2025-02-14
- 2024-12-31: Convertible Debt, Current $13.24M.
- 2024-09-30: Convertible Debt, Current $13.64M.
- 2024-06-30: Convertible Debt, Current $12.04M.
- 2023-12-31: Convertible Debt, Current $14.00M.
| Period end | Convertible Debt, Current |
|---|---|
| 2024-12-31 | $13.24M 10-K · filed 2025-02-14 |
| 2024-09-30 | $13.64M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $12.04M 10-Q · filed 2024-08-09 |
| 2023-12-31 | $14.00M 10-K · filed 2025-02-14 |